This group postulated that ADAM15 can promote prostate cancer progression through different mechanisms: (i) by disrupting cellular attachments to neighboring cells; (ii) by influencing cell signaling in an autocrine or paracrine fashion through the shedding of membrane-bound growth factors; and (iii) by disrupting cellular interactions with the extracellular matrix and basement membrane [169]. Here, ADAM15 is linked to prostate cancer.